Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans SJ McConkey, WHH Reece, VS Moorthy, D Webster, S Dunachie, ... Nature medicine 9 (6), 729-735, 2003 | 727 | 2003 |
Characterization of the inflammatory response to severe COVID-19 illness OJ McElvaney, NL McEvoy, OF McElvaney, TP Carroll, MP Murphy, ... American journal of respiratory and critical care medicine 202 (6), 812-821, 2020 | 711 | 2020 |
Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara DP Webster, S Dunachie, JM Vuola, T Berthoud, S Keating, SM Laidlaw, ... Proceedings of the National Academy of Sciences 102 (13), 4836-4841, 2005 | 334 | 2005 |
Case series of acute abdominal surgery in rural Sierra Leone SJ McConkey World journal of surgery 26, 509-513, 2002 | 167 | 2002 |
Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against … SM Keating, P Bejon, T Berthoud, JM Vuola, S Todryk, DP Webster, ... The Journal of Immunology 175 (9), 5675-5680, 2005 | 163 | 2005 |
Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa ME Mendy, T Welzel, OA Lesi, P Hainaut, AJ Hall, MH Kuniholm, ... Journal of viral hepatitis 17 (2), 115-122, 2010 | 160 | 2010 |
Long-term protection against carriage of hepatitis B virus after infant vaccination MAB Sande, P Waight, M Mendy, P Rayco-Solon, P Hutt, T Fulford, ... The Journal of Infectious Diseases 193 (11), 1528-1535, 2006 | 159 | 2006 |
Synergistic DNA–MVA prime-boost vaccination regimes for malaria and tuberculosis SC Gilbert, VS Moorthy, L Andrews, AA Pathan, SJ McConkey, JM Vuola, ... Vaccine 24 (21), 4554-4561, 2006 | 149 | 2006 |
Maintenance of HIV-specific CD4+ T cell help distinguishes HIV-2 from HIV-1 infection MG Duvall, A Jaye, T Dong, JM Brenchley, AS Alabi, DJ Jeffries, ... The Journal of Immunology 176 (11), 6973-6981, 2006 | 135 | 2006 |
Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers VS Moorthy, S McConkey, M Roberts, P Gothard, N Arulanantham, ... Vaccine 21 (17-18), 1995-2002, 2003 | 131 | 2003 |
Sixteen years of HIV surveillance in a West African research clinic reveals divergent epidemic trends of HIV-1 and HIV-2 MFS van der Loeff, AA Awasana, R Sarge-Njie, M van der Sande, A Jaye, ... International journal of epidemiology 35 (5), 1322-1328, 2006 | 123 | 2006 |
Risk factors for and clinical outcome of congenital cytomegalovirus infection in a peri-urban West-African birth cohort MAB van der Sande, S Kaye, DJC Miles, P Waight, DJ Jeffries, OO Ojuola, ... PloS one 2 (6), e492, 2007 | 113 | 2007 |
Is HIV-2-induced AIDS different from HIV-1-associated AIDS? Data from a West African clinic E Martinez-Steele, AA Awasana, T Corrah, S Sabally, M van der Sande, ... Aids 21 (3), 317-324, 2007 | 111 | 2007 |
Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescence MAB Van der Sande, PA Waight, M Mendy, S Zaman, S Kaye, O Sam, ... PloS one 2 (8), e753, 2007 | 109 | 2007 |
Partially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection JS Cavenaugh, D Awi, M Mendy, AVS Hill, H Whittle, SJ McConkey PloS one 6 (2), e14626, 2011 | 106 | 2011 |
Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers DP Webster, S Dunachie, S McConkey, I Poulton, AC Moore, M Walther, ... Vaccine 24 (15), 3026-3034, 2006 | 91 | 2006 |
Readability of online COVID-19 health information: a comparison between four English speaking countries AP Worrall, MJ Connolly, A O’Neill, M O’Doherty, KP Thornton, C McNally, ... BMC Public Health 20, 1-12, 2020 | 90 | 2020 |
Results of a comprehensive infection control program for reducing surgical-site infections in coronary artery bypass surgery SJ McConkey, PB L'Ecuyer, DM Murphy, TL Leet, TM Sundt, VJ Fraser Infection Control & Hospital Epidemiology 20 (8), 533-538, 1999 | 88 | 1999 |
An integrated multidisciplinary model of COVID-19 recovery care H O’Brien, MJ Tracey, C Ottewill, ME O’Brien, RK Morgan, RW Costello, ... Irish Journal of Medical Science (1971-) 190, 461-468, 2021 | 82 | 2021 |
Application of real-time PCR to quantify hepatitis B virus DNA in chronic carriers in The Gambia ME Mendy, S Kaye, M Van Der Sande, P Rayco-Solon, PA Waight, ... Virology Journal 3, 1-7, 2006 | 78 | 2006 |